Stoke Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Stoke Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Stoke Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Stoke Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.2M | 90k | 13.50 |
| 2023-12-31 | $517k | 98k | 5.26 |
| 2023-09-30 | $423k | 107k | 3.94 |
| 2023-06-30 | $1.1M | 104k | 10.63 |
| 2023-03-31 | $746k | 90k | 8.33 |
| 2022-12-31 | $838k | 91k | 9.23 |
| 2022-09-30 | $1.0M | 80k | 12.83 |
| 2022-06-30 | $948k | 72k | 13.23 |
| 2022-03-31 | $1.3M | 63k | 21.08 |
| 2021-12-31 | $1.5M | 62k | 24.00 |
| 2021-09-30 | $1.5M | 60k | 25.43 |
| 2021-06-30 | $1.8M | 54k | 33.69 |
| 2021-03-31 | $2.0M | 51k | 38.85 |
| 2020-12-31 | $3.4M | 54k | 61.90 |
| 2020-09-30 | $1.6M | 49k | 33.48 |
| 2020-06-30 | $1.2M | 51k | 23.83 |
| 2020-03-31 | $1.3M | 57k | 22.90 |
| 2019-12-31 | $956k | 34k | 28.37 |
| 2019-09-30 | $530k | 25k | 21.53 |